Evidence map›Paper›PMID 30340417›Full record

ArticleGenes2018

Rob Van Houdt, Ann Provoost, Ado Van Assche, Natalie Leys, Bart Lievens, Kristel Mijnendonckx, Pieter Monsieurs

Open access · goldAbstract read
In one paragraph

Article in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Microorganisms · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rob Van HoudtMicrobiology Unit, Belgian Nuclear Research Centre (SCK•CEN), B-2400 Mol, Belgium. rvhoudto@sckcen.be.ORCID 0000-0002-7459-496X
Ann ProvoostMicrobiology Unit, Belgian Nuclear Research Centre (SCK•CEN), B-2400 Mol, Belgium. aprovoos@sckcen.be.
Ado Van AsscheLaboratory for Process Microbial Ecology and Bioinspirational Management, KU Leuven, B-2860 Sint-Katelijne-Waver, Belgium. ado.vanassche@kuleuven.be.
Natalie LeysMicrobiology Unit, Belgian Nuclear Research Centre (SCK•CEN), B-2400 Mol, Belgium. nleys@sckcen.be.ORCID 0000-0002-4556-5211
Bart LievensLaboratory for Process Microbial Ecology and Bioinspirational Management, KU Leuven, B-2860 Sint-Katelijne-Waver, Belgium. bart.lievens@kuleuven.be.
Kristel MijnendonckxMicrobiology Unit, Belgian Nuclear Research Centre (SCK•CEN), B-2400 Mol, Belgium. kmijnend@sckcen.be.ORCID 0000-0002-2801-1110
Pieter MonsieursMicrobiology Unit, Belgian Nuclear Research Centre (SCK•CEN), B-2400 Mol, Belgium. pmonsieu@sckcen.be.
Belgian Nuclear Research Centre · BEKU Leuven · BE

Funding

Federaal Wetenschapsbeleid C90356
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cupriavidusmetalmobile genetic elementsphenotype microarrayresistance

Identifiers

PMID30340417
PMCPMC6210171
OpenAlexW2896859129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.